History
Though approved in the United States in April 2009, Dysport has a history of use in other countries since 1991. First approved for aesthetic use outside the U.S. in 2001, Dysport has steadily gained in popularity around the world. Today Dysport is marketed and sold for aesthetic use in 36 countries (as of October 2009). With its approval by the U.S. Food and Drug Administration, you, too, may join others worldwide who have been treated with Dysport.
In U.S. clinical studies the most common side effects were nose and throat irritation, headache, injection site skin reaction, upper respiratory tract infection, eyelid swelling, eyelid drooping, sinus inflammation, and nausea. In some cases, Dysport may cause serious side effects, such as swallowing or breathing problems, that may be life threatening. For more information on possible side effects of Dysport, please see the Important Safety Information including Boxed Warning below and the Medication Guide, or talk to your healthcare professional.
